Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product defect recall alert
Huvepharma N.V have contacted wholesale dealers and veterinary surgeons to examine inventory immediately.

Gallifen 200 mg/ml Suspension and Pigfen 200 mg/ml Suspension.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for two products manufactured by Huvepharma N.V.

The recall affects the following finished products from the UK market:

  • two batches of Gallifen 200 mg/ml Suspension for Use in Drinking Water for Chickens and Pheasants
  • six batches of Pigfen 200 mg/ml Suspension for Use in Drinking Water for Pigs.

The VMD writes: 'Fenbendazole content has been found lower than the agreed specification limit and sediment/caking layer is present on bottom of the bottle...Huvepharma N.V have contacted wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.'

The recall affects the following batches only:
 

Product
Batch No.
Expiry date
Gallifen 200mg/ml 19041748008 31/10/2021
Gallifen 200mg/ml 19091748023 30/03/2022
Pigfen 200mg/ml 18061747014 31/12/2020
Pigfen 200mg/ml 18091747020 30/03/2021
Pigfen 200mg/ml 19011747001 31/07/2021
Pigfen 200mg/ml 19031747019 30/09/2021


Further details can be obtained from Laura Kappelle Laura.Kappelle@huvepharma.com

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.